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Abstract
West Virginia ranks second 
nationally in population ≥ 65 years old 
placing our state at greater risk for 
osteoporosis and fracture. The gold 
standard for detecting osteoporosis is 
dual X-ray absorptiometry (DXA), yet 
over half of West Virginia’s counties 
do not have this machine. Due to 
access barriers, a validated phone-
administered fracture prediction tool 
would be beneficial for osteoporosis 
screening.
The World Health Organization’s 
FRAX® fracture prediction tool was 
administered as a phone survey to 45 
patients; these results were compared 
to DXA bone mineral density 
determination.
Results confirmed that the FRAX® 
phone survey is as reliable as DXA in 
detecting osteoporosis or clinically 
significant osteopenia: 92% positive 
predictive value, 100% negative 
predictive value, 100% sensitivity and 
91% specificity when compared to the 
gold standard. These promising results 
allow for the development of 
telephone-based protocols to improve 
osteoporosis detection, referral and 
treatment especially in areas with 
health care access barriers.
Introduction
Osteoporosis detection in West 
Virginia is limited by resources and 
our rural population. West Virginia 
is the second most rural state in 
the nation with over 67% of our 
population living in towns of less 
than 2500 people and 50 of our 55 
counties federally designated, either 
in part or full, as Health Professional 
Shortage Areas or Medically 
Underserved areas.1-3 Additionally, 
16.5% of our population is 65 years 
of age or older (second in the 
nation).4,5 This large cohort means 
that the risk of osteoporosis and 
osteoporosis-related fracture, two 
age-related conditions, is increased 
for West Virginia.6 It is surprising to 
note that over a quarter of a million 
(77%) of West Virginia’s female 
residents over 50 years of age have 
osteoporosis or diminished bone 
mass.7 Nationally, osteoporosis 
remains a public health threat to 
almost 55% of the people aged 
50 years and older.8 The National 
Osteoporosis Foundation (NOF) 
estimates that in the United States, 
10 million people already have the 
disease, while 34 million more are 
estimated to have low bone mass, 
increasing their risk of fracture.8 In 
addition to the personal and local 
burden of osteoporosis, there is 
also a national burden in terms of 
healthcare dollars. Currently, total 
costs in the United States are more 
than $19 billion dollars and this 
number is expected to rise by almost 
50% by 2025. These frightening 
statistics argue for a low cost, widely 
applicable method of screening large 
populations in rural areas where 
the availability of sophisticated 
diagnostic tools such as the dual-
energy x-ray absorptiometry 
(DXA) scanner is limited.
A DXA scan is considered the 
gold standard to assess bone 
mineral density (BMD) and detect 
osteoporosis.9 By calculating BMD, 
physicians are able to evaluate for 
osteoporosis, to assess for risk of 
fracture, and to monitor response to 
treatment. However, in West Virginia, 
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access to DXA scanners is limited, 
with the most recent data suggesting 
only 24 of 55 counties having a free 
standing DXA unit (Figure 1).10 In 
addition to limited access, distance 
is a factor that negatively impacts 
the delivery of rural healthcare.11 A 
20% drop in osteoporosis screening 
rates occurs when a DXA is located 
over 5 miles from a patient.12 This 
combination of a rural and aging 
population places West Virginia at 
the forefront of an “osteoporosis 
epidemic” and effective strategies 
need to be developed to better 
serve the needs of this population. 
This is where FRAX could play 
a role in improving access and 
detection of osteoporosis.
The World Health Organization 
(WHO) has a validated, 
internationally accepted fracture 
prediction tool -- FRAX®-- which is 
used to detect individuals at risk for 
fracture. Independent risk factors 
of the patient are incorporated 
into the FRAX® algorithm and 
consist of: country of origin, age, 
gender, weight, height, previous 
fracture, parental history of hip 
fracture, current smoking, use 
of glucocorticoids, rheumatoid 
arthritis, secondary osteoporosis, 
alcohol consumption (3 or more 
units/day) and, when available, 
BMD at the femoral neck (g/cm2) 
obtained by DXA (Figure 2).13 The 
algorithm corrects for the different 
contributions of each independent 
risk factor to yield the ten year 
probability of sustaining either a hip 
fracture or other major osteoporotic 
fracture.13 When the absolute risk 
of sustaining a hip fracture within 
the next ten years is 3% or above, 
or the risk of major orthopaedic 
fracture is 20% or above, treatment 
is considered cost effective and has 
been shown to decrease the rate of 
subsequent fractures.14-21 Because 
this tool can be used without BMD 
data, we hypothesized that FRAX 
could be used as a phone screening 
tool and would correlate very well 
with osteoporosis detection using the 
gold standard of BMD using DXA.
Methods
This study was IRB approved 
(#396973) and involved four 
steps: (1) identification of a 
pool of rural patients “at risk” for 
fracture; (2) randomly contacting 
patients to see if they would like 
to participate in the research 
protocol; (3) obtaining FRAX and 
DXA information for each patient 
enrolled; and (4) communicating 
these results to the patient and 
primary care provider (PCP).
Figure 1: Map of West Virginia’s 55 counties with highlighted counties 
indicating the presence of a free standing DXA unit. 7
Figure 2: The World Health Organization (WHO) fracture prediction tool 
(FRAX®).13 Adapted with permission from International Osteoporosis 
Foundation, Fracture Risk Assessment Tool Educational Slide-kit. 
Available at http://www.iofbonehealth.org/health-professionals/frax.html.
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Identification of Patients
We determined the variables used 
to screen “at risk” populations in 
Marshall Health’s Allscripts EMR 
by consulting an expert in the field 
of osteoporosis detection and 
screening -- Dr. Richard Dell of 
Kaiser Permanente. Dr. Dell was 
contacted because he uses an EMR 
to automatically identify patients 
for bone health screenings in their 
11-hospital system. Patients were 
screened for inclusion by using the 
population health management 
tool within Allscripts. There were 6 
inclusion criteria and 1 exclusion 
criteria. Inclusion criteria included 
(1) all women 65+ years old; (2) all 
men 70+ years old; (3) all patients 
over 50 years of age with a fracture 
of the proximal humerus, distal 
radius, hip or vertebral compression 
fracture; (4) patients on 3+ months 
of steroids; (5) patients on Lupron; 
and (6) including only patients 
that live within rural and urban 
designations (RUCA’s) consistent 
with rural (requirement of the 
funding mechanism). Exclusion 
criteria included patients already 
completing a DXA scan within 
the past two years. A total of 572 
potential study patients were 
identified. From this list, we excluded 
patients not living within a rural 
RUCA zip code designation.
Contact for Study Participation
From the list of potential study 
patients living in rural RUCA’s, 
two of the authors (FS, KS) 
randomly contacted the patient by 
phone to see if they would like to 
participate in the research protocol. 
A standardized phone discussion 
was generated indicating that we 
were contacting the patient from 
the Department of Orthopaedic 
Surgery at Marshall University and 
conducting a research study on 
weak bones (osteoporosis) and 
this study would include a brief 2-3 
minute phone conversation and by 
participation a free DXA scan would 
be arranged at our testing facility. 
Response was impressive with 
the first 57 phone calls producing 
55 people willing to participate. 
Consultation with a statistician was 
completed as part of the granting 
mechanism and sample size needed 
was determined to be n=45.
FRAX and DXA Completion
Fifty-five study patients completed 
FRAX with the phone survey taking 
an average of two minutes. The 
10-year absolute risk of fracture 
for the patient was then generated 
and recorded and the patient was 
immediately notified of their fracture 
risk. This information was printed 
and mailed to the patient along with 
a voucher for a free DXA scan at 
the Erma Byrd Clinical Center on 
a set date in June or August 2013. 
The free voucher was developed in 
conjunction with the Senior Services 
Division and Cabell Huntington 
Hospital Radiology with the study 
protocol paying for the DXA scans 
with no charges to the study 
patients. A total of 45 patients were 
able to complete the DXA scans. 
Those unable to complete the scans 
on the study dates were contacted 
by the research team nurse (LM) 
and alternative arrangements were 
made including a letter sent to their 
PCP containing their FRAX data.
Communication of Results
All patients received their FRAX 
test results including a professional 
interpretation of the DXA scan 
(n=45) by an International Society 
for Clinical Densitometry (ISCD) 
certified endocrinologist (OO). 
These results were sent by mail 
to the patient and also forwarded 
to the participant’s PCP. The 
research study nurse’s (LM) phone 
number was provided to the study 
participants and she assisted with 
any questions or interpretations of 
the results including coordination 
of follow up if needed. A three 
month follow up phone call was 
completed on all patients (LM).
Results
The total number of patients 
completing the study protocol was 
45 (June 19, 2013- August 27, 
2013). There were 6 males and 39 
females. The age range was 52-81 
years of age with a mean age of 
65.8 years. Results of the FRAX 
phone-screening tool and DXA 
scan were analyzed by two authors 
(TWB, FS). When the absolute 
risk of sustaining a hip fracture in 
a study participant within the next 
ten years was 3% or above, or the 
risk of major osteoporosis fracture 
was 20% or above, the FRAX 
screening was considered positive 
for osteoporosis/clinically significant 
osteopenia and treatment was 
recommended.14-21 FRAX results 
demonstrated 25 patients requiring 
pharmacological management 
(presence of osteoporosis/
clinically significant osteopenia). Of 
note, the FRAX scores were re-
calculated for all participants using 
the empirically determined height 
and weight data obtained during 
DXA scanning. These “corrected” 
scores were used in the final data 
analysis. For the DXA results, 
23 patients were recommended 
to receive pharmacological 
management (Table 1).
Forty-three of 45 patients had 
the CORRECT diagnosis of either 
presence or absence of fracture risk 
threshold requiring treatment with 
100% sensitivity, 91% specificity; 
92% positive predictive value 
Table 1: Results of DXA Scan versus FRAX Predicted Risk of Fracture
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and 100% negative predictive 
value (Table 1). In two patients 
FRAX over-predicted the need for 
pharmacological management. In 
both patients the recommendation 
for pharmacological management 
was reversed if FRAX was 
recalculated using the BMD of the 
femoral neck empirically determined 
with DXA. For these two patients 
additional information is presented.
The first patient was a 77-year-
old female with only one FRAX 
parameter above threshold -- 3.6% 
risk for femoral neck fracture (above 
the treatment threshold of 3%). 
Using the BMD data this risk was 
reduced to 2.1% and was consistent 
with the formal DXA reading of no 
recommendation for pharmacological 
management. The second patient 
was a 64-year-old female with two 
FRAX parameters above threshold 
– 4% risk for femoral neck fracture 
and 21% risk of major osteoporotic 
fracture (above the treatment 
threshold of 20%). Using the BMD 
data these risks were reduced 
to 2.3% and 16%, both below 
thresholds for pharmacological 
management and consistent 
with the formal DXA reading.
Previously, treatment decisions 
for osteoporosis management were 
based solely on BMD testing and 
T-score generation with previous 
publications highlighting that 
identical T-scores can produce vastly 
different fracture risks.22-24 In this 
study cohort, only 10 patients had 
a T-score of -2.5 or lower. In the 23 
patients with final recommendation 
for pharmacological management 
for osteoporosis/clinically significant 
osteopenia, only 39% (9/23) had 
a T-score of -2.5 or lower.
It is worth noting that the three-
month follow-up on all patients 
resulted in 100% returning for 
further osteoporosis evaluation and 
management with their PCP (n=45).
Discussion
In this study, FRAX has been 
used and validated as an effective 
phone-screening tool to determine 
“at risk” populations for osteoporosis/
clinically significant osteopenia. 
There was a 4.4% risk (2/45) of 
over-prediction of fracture risk 
above pharmacological treatment 
thresholds using FRAX algorithms 
calculated without BMD data. This 
risk was reduced to 0% when FRAX 
was recalculated using BMD data 
obtained from DXA. It is clear from 
a recent review that FRAX is useful 
for prediction of pharmacological 
interventions where facilities for 
BMD determination are sparse 
like in West Virginia; but BMD 
should be used in calculations on 
“those close to a probability-based 
intervention threshold”.25 In the two 
patients where FRAX over-prediction 
occurred, both were within 1% of the 
threshold value for treatment and in 
each, DXA was performed, which 
changed the recommendations for 
pharmacological management. It is 
worth noting that osteoporosis is a 
skeletal disorder characterized by 
low bone strength and increased 
risk of fracture; therefore, treatment 
decisions should not be based on 
T-score alone. 22 In this study cohort, 
the majority (61%) of the study 
patients receiving a recommendation 
for pharmacological management 
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for osteoporosis/clinically 
significant osteopenia actually had 
T-scores above -2.5 (14/23).
In summary, detection of patients 
at greatest risk for fracture is 
facilitated by the FRAX tool and can 
be easily accomplished by a phone 
call with nearly equivalent results to 
that of the gold standard DXA scan. 
In a state with limited resources 
and multiple barriers to health care 
access, incorporation of a simple 
phone screening tool will help to 
improve osteoporosis screening, 
detection and treatment which has 
been shown to reduce fracture 
incidence and the fiscal burden 
associated with fracture care.14-21,26,27
Acknowledgements
The authors would like to 
thank the funding provided by 
the competitive granting process 
through Marshall University’s Robert 
C. Byrd Center for Rural Health in 
collaboration with the WV Higher 
Education Policy Commission.
References
 1. West Virginia Rural Health Association. 
Health Care in West Virginia: A 
Workforce Analysis. http://www.hsc.wvu.
edu/media/6607/workforce_analysis.
pdf. Published October 2012.
 2. U.S. Department of Health and Human 
Services. Rural Assistance Center: West 
Virginia. http://www.raconline.org/states/
west-virginia. Accessed January 25, 2015.
 3. West Virginia Health Care Authority. West 
Virginia State Health Plan: Rural Health. 
MacQuest Consulting, Issues Statements. 
http://www.hca.wv.gov/policyandplanning/
Documents/Background%20Material/
shpRurPiper.pdf. Published 1999. 
Accessed January 20, 2015.
 4. Werner CA. United States Census Bureau. 
The Older Population: 2010; 2010 Census 
Briefs. http://www.census.gov/prod/cen2010/
briefs/c2010br-09.pdf. Issued November 
2011. Accessed January 28, 2015.
 5. United States Census Bureau. 2010 
Demographic Profile Data: West Virginia. 
http://factfinder.census.gov/faces/
tableservices/jsf/pages/productview.
xhtml?src=CF. Accessed January 28, 2015.
 6. De Laet CE, van Hout BA, Burger H, Hofman 
A, Pols HA. Bone density and risk of hip 
fracture in men and women: cross-sectional 
analysis. BMJ. 1997; 315(7102): 221-225.
 7. West Virginia Osteoporosis and Arthritis 
Program. West Virginians and Osteoporosis. 
West Virginia Bureau for Public Health. http://
www.wvbonenjoint.org/AboutOsteoporosis/
WestVirginiansandOsteoporosis/tabid/653/
Default.aspx. Accessed January 19, 2015.
 8. National Osteoporosis Foundation (NOF). 
National Osteoporosis Foundation Research 
Agenda. http://nof.org/hcp/research/research-
agenda. Accessed January 22, 2015.
 9. Garg MK, Kharb S. Dual energy X-ray 
absorptiometry: Pitfalls in measurement and 
interpretation of bone mineral density. Indian 
J Endocrinol Metab. 2013; 17(2): 203-210.
10. West Virginia Osteoporosis Prevention 
Education Program. The Burden of 
Osteoporosis in West Virginia. West 
Virginia Department of Health and Human 
Resources. Published January 8, 2004.
11. Buzza C, Ono SS, Turvey C, Wittrock S, 
Noble M, Reddy G, Kaboli PJ, Reisinger 
HS. Distance is relative: unpacking a 
principal barrier in rural healthcare. J Gen 
Intern Med. 2011; 26 Suppl 2: 648-654.
12. Curtis JR, Laster A, Becker DJ, Carbone 
L, Gary LC, Kilgore ML, Matthews RS, 
Morrisey MA, Saag KG, Tanner SB, 
Delzell E. The geographic availability 
and associated utilization of dual-energy 
X-ray absorptiometry (DXA) testing 
among older persons in the United States. 
Osteoporos Int. 2009; 20(9): 1553-1561.
13. International Osteoporosis Foundation. 
FRAX® Identifying people at high risk of 
fracture: WHO Fracture Risk Assessment 
Tool, a new clinical tool for informed 
treatment decisions. http://osteoporosis.org.
za/general/downloads/FRAX-report-09.pdf. 
Switzerland, 2009. FRAX® tool, available 
online at: http://www.shef.ac.uk/FRAX
14. Gehrig LM, Collinge C, Kaufman 
J, Lane JM, O’Connor MI, Tosi LL. 
Osteoporosis: management and 
densitometry for orthopaedic surgeons. 
Instr Course Lect. 2009; 58: 805-815.
15. Assessment of fracture risk and its 
application to screening for postmenopausal 
osteoporosis. Report of a WHO Study 
Group. World Health Organ Tech 
Rep Ser. 1994; 843: 1-129.
16. NIH Consensus Development Panel on 
Osteoporosis Prevention, Diagnosis and 
Therapy. Osteoporosis prevention, diagnosis, 
and therapy. JAMA. 2001; 285(6): 785-795.
17. Gehrig LM, Lane JM, O’Conner MI. 
Osteoporosis: management and treatment 
strategies for orthopaedic surgeons. 
Instr Course Lect. 2009; 58: 817-832.
18. Dawson-Hughes B, Tosteson AN, Melton 
LJ 3rd, Baim S, Favus MJ, Khosla S, 
Lindsay RL; National Osteoporosis 
Foundation Guide Committee. Implications 
of absolute fracture risk assessment for 
osteoporosis practice guidelines in the USA. 
Osteoporos Int. 2008; 19(4): 449-458.
19. Siris ES, Chen YT, Abbott TA, Barrett-Connor 
E, Miller PD, Wehren LE, Berger ML. Bone 
mineral density thresholds for pharmacological 
intervention to prevent fractures. Arch 
Intern Med. 2004; 164(10): 1108-1112.
20. Bouxsein ML, Kaufman J, Tosi L, Cummings 
S, Lane J, Johnell O. Recommendations for 
optimal care of the fragility fracture patient 
to reduce the risk of future fracture. J Am 
Acad Orthop Surg. 2004; 12(6): 385-395.
21. Tosteson AN, Melton LJ 3rd, Dawson-
Hughes B, Baim S, Favus MJ, Khosia 
S, Lindsay RL; National Osteoporosis 
Foundation Guide Committee. Cost-
effective osteoporosis treatment 
thresholds: the United States perspective. 
Osteoporos Int. 2008; 19(4): 437-47.
22. Shuler FD, Conjeski J. Defining bone health 
and fracture risk in West Virginia: the World 
Health Organization FRAX assessment 
tool. WV Med J. 2011; 107(5): 12-17.
23. Shuler FD, Conjeski J, Kendall D, Salava J. 
Understanding the burden of osteoporosis 
and use of the World Health Organization 
FRAX. Orthopedics. 2012; 35(9): 798-805.
24. Shuler FD, Conjeski JM, Hamilton 
RL. Incorporating the WHO FRAX 
assessment tool into nursing practice. 
Am J Nurs. 2011; 111(8): 59-62.
25. Kanis JA, Harvey NC, Johansson H, Oden 
A, Leslie WD, McCloskey EV. FRAX and 
fracture prediction without bone mineral 
density. Climacteric. 2015; 21: 1-8.
26. Haaga J. The aging of Appalachia. Population 
Reference Bureau, April 2004. http://www.
arc.gov/images/reports/aging/aging.pdf
27. Bureau for Public Health. West Virginia 
Behavior Risk Factor Survey Report 2006. 
Charleston, WV: West Virginia Department 
of Health and Human Resources, Office 
of Epidemiology and Health Promotion.
21.  According to the WV Osteoporosis and Arthritis 
Program, how many WV counties have DXA 
scanners?
 a. 55 counties
 b. 40 counties
 c. 24 counties
22.  The FRAX fracture prediction tool provides an 
absolute 10-year risk of hip or major osteoporotic 
fracture.  Can this tool be used without having BMD 
of the femoral neck?
 a. Yes
 b. No
23.  Current recommendation for treatment of 
osteoporosis and clinically significant osteopenia 
are based on the risk of fracture. Which strategy 
below would provide the most utility at 
determination of those greatest at risk for fracture?
 a. T score alone
 b. Z score alone
 c. Physical examination
 d.  FRAX score (>3% for hip frature and >10% risk 
for major osteoporosis fracture)
 e.  FRAX score (>3% for hip fracture and >20% for 
major osteoporosis fracture)
CME Post-Test
